The National Medical Products Administration (NMPA) has released the 88th batch of reference drugs for the Generic Quality Consistency Evaluation (GQCE) work. This update is part of the ongoing efforts to ensure the quality and efficacy of generic drugs in the Chinese market.
Details of the Release
The latest batch includes 50 new specifications and 19 specifications with modifications. This comprehensive update aims to provide a robust framework for the evaluation of generic drugs, ensuring they meet the same high standards as their branded counterparts.
Significance of the Update
By regularly updating the reference drug list, the NMPA continues to enhance the regulatory environment for generic drugs. This helps in maintaining the quality and consistency of generic medications, ultimately benefiting patients by providing them with reliable and cost-effective treatment options.-Fineline Info & Tech
